Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

By R. Baughman, M. Drent, M. Kavuru, M. Judson, U. Costabel, R. D. du Bois, C. Albera, Martin H. Brutsche, Gerald S. Davis, J. Donohue and 6 more. American Journal of Respiratory and Critical Care Medicine, 2006

662 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/c2f85392d24e15762a2b556123f8ef1675fbed1c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Rheumatology

1. D. Tracey
2. Lars Klareskog
3. J. Salfeld
4. P. Tak
5. E. Sasso

Citations in the corpus

• Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. (2008, methodology): “, Larsen, R., Sorensen, L. K., Nielsen, S., Hansen, M. B., Svenson, M., et al. (2004). TNF and LT binding capacities in the plasma of”